Division 3.3.4.3 Preventing drug use and drug related harm:

Addressing the issue of new trends with regard to synthetic drugs' use among young people, in particular in the context of polydrug use, by developing or strengthening a system of exchange of information between Member States that could lead to the development, implementation and evaluation of good practices for demand reduction in this specific domain. [Financing mechanism: Call for proposals]

Reviewing the good practices in preventing drug-related blood-borne infectious diseases, in particular hepatitis (B/C), among injecting drug users to provide adequate guidance documents for practitioners and patients from different settings and vulnerable groups having taken into account an evaluation of the health, social, and economic impacts. [Financing mechanism: Call for proposals]